Overview

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Status:
Completed

Trial end date:
2007-07-01

Target enrollment:

Participant gender:

Summary

Patients with Parkinson's Disease (PD) will be divided into 2 groups at each study center at their first visit based on the drugs they are taking for their PD: - Group 1 Patients using Azilect and no other therapy. - Group 2 Azilect in combination with other medications like Levodopa, Mirapex, or Requip.

Phase:

Phase 4

Details

Lead Sponsor:

Teva Neuroscience, Inc.

Treatments:

Levodopa
Pramipexole
Rasagiline
Ropinirole